Liver Diseases  >>  candesartan cilexetil  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
candesartan cilexetil / Generic mfg.
NCT00930995: Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

Withdrawn
2
0
US
Candesartan, Atacand, Placebo
Kaiser Permanente, University of California, Davis
Hepatitis C
 
 
NCT00990639: Effect of Candesartan in Alcoholic Liver Fibrosis

Completed
1/2
85
RoW
candesartan for hepatic fibrosis, atacand for hepatic fibrosis
Yonsei University
Alcoholic Liver Disease
12/08
03/09

Download Options